SEC 13F Intelligence

Unified Investment Management / HALO

Unified Investment Management’s Halozyme Therapeutics Inc Position

Does Unified Investment Management own Halozyme Therapeutics Inc (HALO)? Yes — 21.3K shares worth $1M (+1.41% of its 13F portfolio) as of Q1 2026, down from 21.6K shares the prior filed quarter.

Position Value
$1M
Q1 2026
Shares
21.3K
% of Portfolio
+1.41%
Quarters Held
6
currently held

Position History HALO

Reported value by quarter
Q4 ’24: $895,242Q4 ’24Q1 ’25: $1MQ1 ’25Q2 ’25: $1MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $1MQ4 ’25Q1 ’26: $1MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202621.3K$1M+1.41%
Q4 202521.6K$1M+1.46%
Q3 202521.9K$2M+1.60%
Q2 202522.2K$1M+1.24%
Q1 202521.3K$1M+1.61%
Q4 202418.7K$895,242+1.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Unified Investment Management’s full portfolio or all institutional holders of HALO.